BR
Basecamp Research
United Kingdom · Biotech · AI
Basecamp Research builds biological AI models from genomic data to help design therapeutics, including protein-based medicines.
Product and customers
Its EDEN models learn from genomic data to support the design of therapeutic proteins and advance the company’s in vivo cell-therapy pipeline.
The company develops AI models and therapeutic programs from biological and genomic data, with pharmaceutical partnerships supporting translation into drug discovery and development.
- Headquarters
- London
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Series C | $140M | S32 — LeadCatalio Capital Management — ParticipantEuropean Tech Collective — ParticipantFirebrand River Capital — ParticipantInception Fund — ParticipantKing Philanthropies — ParticipantMenlo Ventures’ Anthology Fund — ParticipantNATO Innovation Fund — ParticipantNVIDIA — ParticipantPostScriptum — ParticipantRedalpine — ParticipantSingular — ParticipantSovereign AI — ParticipantThe Rockefeller Foundation — ParticipantTrue Ventures — Participant |